RAP 0.00% 20.5¢ resapp health limited

Hello @Redbar, Welcome back. While you were away ResApp...

  1. 424 Posts.
    lightbulb Created with Sketch. 356
    Hello @Redbar, Welcome back.

    While you were away ResApp iteration towards learning from past debauchery is very commendable:
    1. Built new revenue streams- Cough counter which differentiates from background noise ( Thank you US trials)
    2. Shortened integration timelines- App clips via text message ( Thank you long integration process of Coviu and Phenix)
    3. Built(read:building )new verticals- Software Development kit( SDK) - Thank you RB and Sanofi
    4. Delighting customers- Extending SDK for consumer Asthma app for Astra Zeneca. Thank you for all of the above.
    In a nutshell building an economic moat (brick by brick in a staggered way). This is what in Venture Capital world is known as “Build Once, Sell Twice model

    What has not changed: communication! I think it’s still Work in Progress. My view, they need a better entrepreneur.

    imo
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.